Pamela Stephenson
Vermogen: 1 M $ op 31-08-2026
Vermogen: 1 M $ op 31-08-2026
Ms. Pamela Stephenson is a Chief Commercial Officer at Disc Medicine, Inc. Ms. Stephenson was previously employed as a Chief Commercial Officer by Albireo Pharma, Inc., an Independent Director by Zynerba Pharmaceuticals, Inc., and a Vice President-Global Market Access & Value by Vertex Pharmaceuticals, Inc. She received her undergraduate degree from Brown University and a graduate degree from Boston University School of Public Health.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,05% | 22-04-2026 | 18.665 ( 0,05% ) | 1 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 26-02-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 10-10-2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01-04-2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01-03-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau